KR102581432B1 - Waxing composition having pain relief and skin soothing effect - Google Patents
Waxing composition having pain relief and skin soothing effect Download PDFInfo
- Publication number
- KR102581432B1 KR102581432B1 KR1020230022379A KR20230022379A KR102581432B1 KR 102581432 B1 KR102581432 B1 KR 102581432B1 KR 1020230022379 A KR1020230022379 A KR 1020230022379A KR 20230022379 A KR20230022379 A KR 20230022379A KR 102581432 B1 KR102581432 B1 KR 102581432B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- extract
- skin
- waxing
- Prior art date
Links
- 238000004018 waxing Methods 0.000 title claims abstract description 91
- 230000000694 effects Effects 0.000 title claims abstract description 80
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 208000002193 Pain Diseases 0.000 title claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 83
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000004615 ingredient Substances 0.000 claims abstract description 35
- 230000008569 process Effects 0.000 claims abstract description 31
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 22
- 239000002585 base Substances 0.000 claims description 24
- 239000001993 wax Substances 0.000 claims description 24
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 23
- 230000037303 wrinkles Effects 0.000 claims description 21
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 20
- 230000003779 hair growth Effects 0.000 claims description 18
- 241001474374 Blennius Species 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- 230000002401 inhibitory effect Effects 0.000 claims description 14
- 239000002480 mineral oil Substances 0.000 claims description 10
- 235000010446 mineral oil Nutrition 0.000 claims description 10
- 239000004408 titanium dioxide Substances 0.000 claims description 10
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 9
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 9
- 239000004006 olive oil Substances 0.000 claims description 9
- 235000008390 olive oil Nutrition 0.000 claims description 9
- 239000010667 rosehip oil Substances 0.000 claims description 9
- 239000000811 xylitol Substances 0.000 claims description 9
- 235000010447 xylitol Nutrition 0.000 claims description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 9
- 229960002675 xylitol Drugs 0.000 claims description 9
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 8
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 8
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 claims description 8
- 239000003240 coconut oil Substances 0.000 claims description 8
- 235000019864 coconut oil Nutrition 0.000 claims description 8
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 239000012188 paraffin wax Substances 0.000 claims description 8
- 239000000049 pigment Substances 0.000 claims description 8
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 8
- 239000009141 Houttuynia cordata plant extract Substances 0.000 claims description 7
- 229940069521 aloe extract Drugs 0.000 claims description 7
- 229940078580 c30-45 alkyl methicone Drugs 0.000 claims description 7
- 229940094952 green tea extract Drugs 0.000 claims description 7
- 235000020688 green tea extract Nutrition 0.000 claims description 7
- 238000010306 acid treatment Methods 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000011593 sulfur Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- 229940089116 arnica extract Drugs 0.000 claims description 5
- 235000020737 peppermint extract Nutrition 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 244000144927 Aloe barbadensis Species 0.000 claims description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 4
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 210000001320 hippocampus Anatomy 0.000 claims description 3
- 241000205585 Aquilegia canadensis Species 0.000 claims 3
- 244000301850 Cupressus sempervirens Species 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 abstract description 7
- 201000004624 Dermatitis Diseases 0.000 abstract description 7
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 7
- 210000003491 skin Anatomy 0.000 description 82
- 238000002360 preparation method Methods 0.000 description 39
- 206010040954 Skin wrinkling Diseases 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000036556 skin irritation Effects 0.000 description 7
- 231100000475 skin irritation Toxicity 0.000 description 7
- 241001570521 Lonicera periclymenum Species 0.000 description 6
- 230000001747 exhibiting effect Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- -1 iridoids Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- 241000264877 Hippospongia communis Species 0.000 description 2
- 240000000691 Houttuynia cordata Species 0.000 description 2
- 235000013719 Houttuynia cordata Nutrition 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 239000007765 cera alba Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000005722 itchiness Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000208983 Arnica Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 150000008360 acrylonitriles Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
- 125000005262 alkoxyamine group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940045713 antineoplastic alkylating drug ethylene imines Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical class C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000005179 haloacetyl group Chemical group 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008975 immunomodulatory function Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- OKXGHXHZNCJMSV-UHFFFAOYSA-N nitro phenyl carbonate Chemical compound [O-][N+](=O)OC(=O)OC1=CC=CC=C1 OKXGHXHZNCJMSV-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- RDBMUARQWLPMNW-UHFFFAOYSA-N phosphanylmethanol Chemical compound OCP RDBMUARQWLPMNW-UHFFFAOYSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/04—Depilatories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물에 관한 것으로, 더욱 상세하게는 우수한 제모효과를 나타내며, 왁싱 과정에서 발생하는 통증을 완화하고 피부를 진정시킬 뿐만 아니라, 세균감염으로 인한 피부염증을 억제하는 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물에 관한 것이다.The present invention relates to a composition for waxing that exhibits pain relief and skin soothing effects. More specifically, it exhibits an excellent hair removal effect, not only relieves pain occurring during the waxing process and soothes the skin, but also relieves skin inflammation caused by bacterial infection. It relates to a composition for waxing that exhibits pain relief and skin soothing effects that suppresses.
현대사회에서는 외모에 대한 관심과 미용관리 행동의 범위가 확대되어 미용산업은 외모를 개선하는 역할과 위생적이고 건강한 아름다움을 추구하는 다양한 분야로 확대되고 있다.In modern society, interest in appearance and the scope of beauty management behavior have expanded, and the beauty industry is expanding into various fields that play a role in improving appearance and pursue hygienic and healthy beauty.
특히, 제모관련 산업의 경우 현대사회에서 요구하는 새로운 미용관리의 한 부분으로 정착되고 있는 실정으로, 제모(왁싱)는 미용학적으로 체모가 저해요소로 보일 때 이를 제거하는 것으로, 다양한 방법으로 얼굴, 목, 다리, 겨드랑이, 비키니 라인 및 음부 주변 등의 신체부위에 난 불필요한 체모를 제거하는 것을 일컷는다.In particular, in the case of the hair removal industry, it is becoming established as a part of the new beauty care required in modern society. Hair removal (waxing) is a method of removing body hair when it appears to be a cosmetic obstacle, and is used in various ways to remove hair from the face, face, and face. It refers to removing unnecessary hair from body parts such as the neck, legs, armpits, bikini line, and around the pubic area.
종래에는 왁싱의 주 고객으로 심미적인 부분과 위생적인 부분을 목적으로 하는 20 내지 30대 여성들이 주를 이루었으나, 최근에는 남성들까지 왁싱 시술에 관심을 가지게 되면서 자연스럽게 대중화가 이루어지고 있다.Previously, the main customers of waxing were women in their 20s and 30s for aesthetic and hygienic purposes, but recently, as even men have become interested in waxing, it is naturally becoming popular.
그러나, 체모는 일반적으로 다른 신체부위보다 예민하고 얇은 부위에 주로 분포하고 있어, 체모를 제거하는 왁싱 시술은 상당한 고통을 유발하며, 왁싱 후에는 모근에 상처가 발생되어 세균감염으로 인한 피부트러블이나 염증이 발생되고 피부가 민감해질 수 있는 문제점이 있었다.However, body hair is generally distributed in areas that are more sensitive and thin than other body parts, so waxing to remove body hair causes considerable pain, and after waxing, wounds occur at the hair roots, causing skin problems or inflammation due to bacterial infection. There was a problem that this occurred and the skin could become sensitive.
종래에는 상기의 문제점을 해소하기 위해 주로 숙력된 시술자의 기술에 의지하거나, 왁싱 후에 피부를 진정시키는 성분을 도포하는 수준을 적용하는 것에 만족하였으나, 숙련된 시술자는 기술수준을 객관적으로 가늠하기 어렵고, 세균감염으로 인한 염증문제는 여전한 문제점으로 남아있으면, 왁싱 후에 피부를 진정시키는 성분을 도포하는 것은 이미 통증이나 염증이 발생한 후에 진행되는 사후 처리에 불과하여 소비자들의 불만이 높은 문제점이 있었다.In the past, in order to solve the above problems, people were satisfied with relying on the skills of skilled practitioners or applying ingredients that soothe the skin after waxing. However, it is difficult for skilled practitioners to objectively assess the level of skill. While inflammation caused by bacterial infection still remains a problem, applying ingredients that soothe the skin after waxing is merely a post-processing that takes place after pain or inflammation has already occurred, which has resulted in high consumer dissatisfaction.
본 발명의 목적은 우수한 제모효과를 나타내며, 왁싱 과정에서 발생하는 통증을 완화하고 피부를 진정시킬 뿐만 아니라, 세균감염으로 인한 피부염증을 억제하는 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제공하는 것이다.The object of the present invention is to provide a waxing composition that exhibits excellent hair removal effects, relieves pain occurring during the waxing process, soothes the skin, and also has a pain relieving and skin soothing effect that suppresses skin inflammation caused by bacterial infection. will be.
본 발명의 목적은 왁스 베이스 100 중량부, 천연추출물 25 내지 40 중량부, 피부진정 성분 10 내지 30 중량부 및 천연 항균제 1 내지 5 중량부로 이루어지며, 상기 왁스 베이스는 글리세릴로지네이트 100 중량부, 로진 10 내지 20 중량부, 에틸렌비닐아세테이트 5 내지 10 중량부, 파라핀 1 내지 3 중량부, C30-45 알킬메티콘 5 내지 10 중량부, 세라알바 5 내지 20 중량부, 미네랄 오일 10 내지 25 중량부, 하이드로제네이티드 코코넛 오일 10 내지 25 중량부, 법제유황 분말 5 내지 10 중량부, 티타늄 디옥사이드 5 내지 10 중량부 및 안료 5 내지 10 중량부로 이루어지고, 상기 해조류 추출물 분말 100 중량부, 녹차 추출물 80 내지 120 중량부, 율피 추출물 80 내지 120 중량부, 쌀겨 추출물 80 내지 120 중량부 및 알로에 추출물 70 내지 90 중량부로 이루어지며, 상기 피부진성성분은 올리브 오일 100 중량부, 로즈힙오일 80 내지 120 중량부 및 자일리톨 20 내지 50 중량부로 이루어지는 것을 특징으로 하는 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제공함에 의해 달성된다.The purpose of the present invention is to consist of 100 parts by weight of a wax base, 25 to 40 parts by weight of natural extract, 10 to 30 parts by weight of a skin soothing ingredient, and 1 to 5 parts by weight of a natural antibacterial agent, wherein the wax base contains 100 parts by weight of glyceryl loginate, 10 to 20 parts by weight of rosin, 5 to 10 parts by weight of ethylene vinyl acetate, 1 to 3 parts by weight of paraffin, 5 to 10 parts by weight of C30-45 alkylmethicone, 5 to 20 parts by weight of Cera Alba, 10 to 25 parts by weight of mineral oil , 10 to 25 parts by weight of hydrogenated coconut oil, 5 to 10 parts by weight of sulfur powder, 5 to 10 parts by weight of titanium dioxide, and 5 to 10 parts by weight of pigment, 100 parts by weight of the seaweed extract powder, and 80 to 10 parts by weight of green tea extract. It consists of 120 parts by weight, 80 to 120 parts by weight of Yulpi extract, 80 to 120 parts by weight of rice bran extract, and 70 to 90 parts by weight of aloe extract, and the dermatological ingredients include 100 parts by weight of olive oil, 80 to 120 parts by weight of rosehip oil, and xylitol. This is achieved by providing a waxing composition exhibiting pain relief and skin soothing effects, which is comprised of 20 to 50 parts by weight.
본 발명의 바람직한 특징에 따르면, 상기 천연 항균제는 금은화 추출물, 어성초 추출물 및 상황버섯 추출물로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to a preferred feature of the present invention, the natural antibacterial agent is composed of one or more selected from the group consisting of honeysuckle extract, Houttuynia cordata extract, and Phellodendron chinensis extract.
본 발명의 더 바람직한 특징에 따르면, 상기 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물에는 상기 왁스 베이스 100 중량부 대비 피부주름 개선제 5 내지 10 중량부가 더 함유되며, 상기 피부주름 개선제는 긴기아남 추출물, 담팔수 추출물 및 참식나무 추출물로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the waxing composition exhibiting the pain relief and skin soothing effect further contains 5 to 10 parts by weight of a skin wrinkle improving agent relative to 100 parts by weight of the wax base, and the skin wrinkle improving agent is Gingianam extract. , it shall be composed of one or more selected from the group consisting of ginseng extract and cypress extract.
본 발명의 더욱 바람직한 특징에 따르면, 상기 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물에는 상기 왁스 베이스 100 중량부 대비 체모성장 억제용 조성물 1 내지 3 중량부가 더 함유되며, 상기 체모성장 억제용 조성물은 하마엘리스 추출물, 아르니카 추출물, 박하 추출물, 소목 추출물 및 알로에 베라 겔로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the waxing composition exhibiting pain relief and skin soothing effects further contains 1 to 3 parts by weight of a composition for inhibiting hair growth based on 100 parts by weight of the wax base, and the composition for inhibiting hair growth includes It is to be composed of one or more selected from the group consisting of hippocampus extract, arnica extract, peppermint extract, arborvitae extract and aloe vera gel.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 법제유황 분말은 광물성 유황을 700 내지 900℃의 온도로 가열한 후에 100 내지 120℃의 온도로 냉각하는 과정을 5 내지 10회 반복한 후에, 100 내지 200㎛의 입자크기로 분쇄하고 알칼리 처리와 산처리를 반복하여 pH를 6.9 내지 7.1의 범위로 조절하는 과정을 통해 제조되는 것으로 한다.According to an even more preferred feature of the present invention, the legal sulfur powder is obtained by repeating the process of heating mineral sulfur to a temperature of 700 to 900 ° C. and then cooling it to a temperature of 100 to 120 ° C. 5 to 10 times, and then heating it to a temperature of 100 to 200 ° C. It is manufactured through a process of grinding to a particle size of ㎛, repeating alkali treatment and acid treatment to adjust the pH to the range of 6.9 to 7.1.
본 발명에 따른 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물은 우수한 제모효과를 나타내며, 왁싱 과정에서 발생하는 통증을 완화하고 피부를 진정시킬 뿐만 아니라, 세균감염으로 인한 피부염증을 억제하는 탁월한 효과를 나타낸다.The composition for waxing that exhibits pain relief and skin soothing effects according to the present invention has an excellent hair removal effect, not only relieves pain occurring during the waxing process and soothes the skin, but also has an excellent effect of suppressing skin inflammation caused by bacterial infection. indicates.
이하에는, 본 발명의 바람직한 실시예와 각 성분의 물성을 상세하게 설명하되, 이는 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 발명을 용이하게 실시할 수 있을 정도로 상세하게 설명하기 위한 것이지, 이로 인해 본 발명의 기술적인 사상 및 범주가 한정되는 것을 의미하지는 않는다.Below, preferred embodiments of the present invention and the physical properties of each component are described in detail, but are intended to be described in detail so that those skilled in the art can easily practice the invention. This does not mean that the technical idea and scope of the present invention are limited.
본 발명에 따른 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물은 왁스 베이스, 천연추출물, 피부진정 성분 및 천연 항균제로 이루어지며, 왁스 베이스 100 중량부, 천연추출물 25 내지 40 중량부, 피부진정 성분 10 내지 30 중량부 및 천연 항균제 1 내지 5 중량부로 이루어지는 것이 바람직하다.The waxing composition showing pain relief and skin soothing effects according to the present invention consists of a wax base, natural extracts, skin soothing ingredients, and natural antibacterial agents, comprising 100 parts by weight of wax base, 25 to 40 parts by weight of natural extracts, and 10 parts by weight of skin soothing ingredients. It is preferable that it consists of 1 to 30 parts by weight and 1 to 5 parts by weight of a natural antibacterial agent.
상기 왁스 베이스는 본 발명에 따른 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물의 주재료가 되는 성분으로, 글리세릴로지네이트, 로진, 에틸렌비닐아세테이트, 파라핀, C30-45 알킬메티콘, 세라알바, 미네랄 오일, 하이드로제네이티드 코코넛 오일, 법제유황 분말 및 안료로 이루어지는데, 글리세릴로지네이트 100 중량부, 로진 10 내지 20 중량부, 에틸렌비닐아세테이트 5 내지 10 중량부, 파라핀 1 내지 3 중량부, C30-45 알킬메티콘 5 내지 10 중량부, 세라알바 5 내지 20 중량부, 미네랄 오일 10 내지 25 중량부, 하이드로제네이티드 코코넛 오일 10 내지 25 중량부, 법제유황 분말 5 내지 10 중량부, 티타늄 디옥사이드 5 내지 10 중량부 및 안료 5 내지 10 중량부로 이루어지는 것이 바람직하다.The wax base is the main ingredient of the waxing composition showing pain relief and skin soothing effects according to the present invention, and includes glyceryl loginate, rosin, ethylene vinyl acetate, paraffin, C30-45 alkylmethicone, cera alba, and mineral. It consists of oil, hydrogenated coconut oil, modified sulfur powder and pigments, including 100 parts by weight of glyceryl loginate, 10 to 20 parts by weight of rosin, 5 to 10 parts by weight of ethylene vinyl acetate, 1 to 3 parts by weight of paraffin, C30- 45 5 to 10 parts by weight of alkylmethicone, 5 to 20 parts by weight of Cera Alba, 10 to 25 parts by weight of mineral oil, 10 to 25 parts by weight of hydrogenated coconut oil, 5 to 10 parts by weight of legal sulfur powder, 5 to 10 parts by weight of titanium dioxide It is preferably comprised of 10 parts by weight and 5 to 10 parts by weight of pigment.
상기 글리세릴로지네이트는 수용성 고분자의 작용으로 제거하고자 하는 체모의 표면에 필름 형성력을 향상시켜 높은 제모 효과를 나타내도록 하는 역할을 하는데, 상기 로진 및 에틸렌비닐아세테이트 성분과 혼합되면 상호작용을 통해 제모효과가 월등하게 향상될 수 있다.The glyceryl loginate serves to exhibit a high hair removal effect by improving the film forming ability on the surface of the hair to be removed through the action of a water-soluble polymer. When mixed with the rosin and ethylene vinyl acetate components, the hair removal effect is achieved through interaction. can be significantly improved.
또한, 상기 세라알바는 5 내지 20 중량부가 함유되는데, 벌집을 가열압착 또는 용제추출 하여 얻어지는 고체성분으로, 벌집의 벽을 만들기 위해 꿀벌의 복부에서 분비되는 점착성이 있는 비결정성 물질로 탈취 및 탈색 과정을 거친 후 사용될 수 있는데, 피부에 코팅막을 형성하여 피부가 수분을 빼앗겨 건조해지지 않도록 예방하고 화학 성분들로부터 피부를 보호하는 역할을 하는데, 상기 세라알바의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 세라알바의 함량이 20 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 본 발명에 따른 왁싱용 조성물의 제모 효과가 저하될 뿌남 아니라, 왁싱 후 피부에 세라알바의 잔존물이 다량 존재하게 되기 때문에 바람직하지 못하다.In addition, the Cera alba contains 5 to 20 parts by weight, which is a solid ingredient obtained by heat compression or solvent extraction of honeycomb. It is a sticky amorphous substance secreted from the abdomen of bees to make the walls of honeycombs and is used in the deodorizing and discoloring process. It can be used after going through the process. It forms a coating film on the skin, preventing the skin from losing moisture and drying out, and protecting the skin from chemical ingredients. If the content of Cera Alba is less than 5 parts by weight, the above effect is not effective. It is insignificant, and if the content of Cera Alba exceeds 20 parts by weight, the above effect is not significantly improved and the hair removal effect of the waxing composition according to the present invention is reduced. In addition, a large amount of Cera Alba remains on the skin after waxing. It is undesirable because it exists.
또한, 상기 미네랄 오일은 10 내지 25 중량부가 함유되는데, 왁싱용 조성물을 구성하는 각 성분이 고르게 혼합되어 균질한 물성을 나타낼 수 있도록 하며, 피부에 접촉시 피부가 건조해지거나 가려움증이 발생되는 것을 억제하는 역할을 하는데, 상기 미네랄 오일의 함량이 10 중량부 미만이면 상기의 효과가 미미하며, 상기 미네랄 오일의 함량이 25 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 왁싱용 조성물의 제모 효과를 저하시킬 뿐만 아니라, 점도를 지나치게 증가시켜 사용감을 저하시킬 수 있다.In addition, the mineral oil contains 10 to 25 parts by weight, which ensures that each component constituting the waxing composition is evenly mixed to exhibit homogeneous physical properties, and prevents skin from drying out or causing itching when in contact with the skin. If the content of the mineral oil is less than 10 parts by weight, the effect is minimal, and if the content of the mineral oil exceeds 25 parts by weight, the effect is not significantly improved and the hair removal effect of the waxing composition is reduced. In addition to lowering the viscosity, the feeling of use may be reduced by excessively increasing the viscosity.
또한, 상기 법제유황 분말은 5 내지 10 중량부가 함유되며, 왁싱과정에서 제모부위에 도포되는 왁싱 조성물에 피지 억제효과를 부여하여 피부트러블을 예방하고, 거친 피부를 개선하는 역할을 한다.In addition, the legal sulfur powder contains 5 to 10 parts by weight, and serves to prevent skin troubles and improve rough skin by imparting a sebum suppressing effect to the waxing composition applied to the hair removal area during the waxing process.
이때, 상기 법제유황 분말은 광물성 유황을 700 내지 900℃의 온도로 가열한 후에 100 내지 120℃의 온도로 냉각하는 과정을 5 내지 10회 반복한 후에, 100 내지 200㎛의 입자크기로 분쇄하고, 알칼리 처리와 산처리를 반복하여 pH를 6.9 내지 7.1의 범위로 조절하는 과정을 통해 제조되는 것이 바람직한데, 상기의 과정을 통해 제조되는 법제유황 분말의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 법제유황 분말의 함량이 10 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 왁싱용 조성물의 제모효과가 저하될 수 있다.At this time, the legal sulfur powder is prepared by repeating the process of heating mineral sulfur to a temperature of 700 to 900 ℃ and then cooling it to a temperature of 100 to 120 ℃ 5 to 10 times, and then grinding it to a particle size of 100 to 200 ㎛, It is preferable to manufacture it through a process of repeating alkali treatment and acid treatment to adjust the pH to the range of 6.9 to 7.1. If the content of the legal sulfur powder manufactured through the above process is less than 5 parts by weight, the above effect is minimal. If the content of the legal sulfur powder exceeds 10 parts by weight, the hair removal effect of the waxing composition may be reduced while the above effect is not significantly improved.
또한, 티타늄 디옥사이드는 5 내지 10 중량부가 함유되며, 본 발명에 따른 왁스 베이스가 함유되는 왁싱용 조성물로 제조되는 필름막의 기계적 물성을 향상시켜 제모효과를 향상시키는 역할을 하는데, 상기 티타늄 디옥사이드의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 티타늄 디옥사이드의 함량이 10 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 피부자극을 유발하기 때문에 바람직하지 못하다.In addition, titanium dioxide is contained in an amount of 5 to 10 parts by weight and plays a role in improving the hair removal effect by improving the mechanical properties of the film film manufactured with the waxing composition containing the wax base according to the present invention. The content of titanium dioxide is If the content of titanium dioxide is less than 5 parts by weight, the effect is minimal, and if the titanium dioxide content exceeds 10 parts by weight, the effect is not significantly improved and it causes skin irritation, which is undesirable.
상기 천연추출물은 25 내지 40 중량부가 함유되며, 해조류 추출물 분말 100 중량부, 녹차 추출물 80 내지 120 중량부, 율피 추출물 80 내지 120 중량부, 쌀겨 추출물 80 내지 120 중량부 및 알로에 추출물 70 내지 90 중량부로 이루어지는데, 본 발명에 따른 왁싱용 조성물에 제모 효과를 향상시킬 뿐만 아니라, 피부 부착 및 탈착이 용이하여 왁싱용 조성물이 피부에 잔존하는 현상을 억제하며 왁싱과정에서 통증을 줄여주는 역할을 한다.The natural extract contains 25 to 40 parts by weight, 100 parts by weight of seaweed extract powder, 80 to 120 parts by weight of green tea extract, 80 to 120 parts by weight of Yulpi extract, 80 to 120 parts by weight of rice bran extract, and 70 to 90 parts by weight of aloe extract. This not only improves the hair removal effect of the waxing composition according to the present invention, but also facilitates attachment and detachment from the skin, thereby suppressing the phenomenon of the waxing composition remaining on the skin and reducing pain during the waxing process.
더욱 상세하게는 상기 해조류 추출물 분말은 왁싱용 조성물을 피부에 적용하는 경우에 피부 자극을 줄여주고, 왁식용 조성물을 피부로부터 탈착/제거시 피부에 잔존물이 남지 않도록 하여 기호도를 향상시키는 역할을 하는데, 상기 해조류는 예를 들어 미역, 다시마, 우뭇가사리 및 톳 등을 사용할 수 있으며, 90℃ 이상의 열수에서 가열하여 열수 추출물을 수득하고, 동결 건조 등의 방법으로 분말화하는 과정을 통해 제조될 수 있는데, 이때, 해조류 100 중량부에 물 200 내지 300 중량부를 혼합하고 90 내지 95℃의 온도에서 2 내지 3시간 동안 가열한 후 채에 걸러진 액상의 추출물을 동결 건조시켜 분말 상태로 제조하는 것이 더욱 바람직하다.More specifically, the seaweed extract powder reduces skin irritation when applying the waxing composition to the skin and improves preference by preventing any residue from remaining on the skin when detaching/removing the waxing composition from the skin. The seaweed can, for example, use seaweed, kelp, agar, and hijiki, and can be manufactured through a process of heating in hot water above 90°C to obtain a hot water extract and powdering it by a method such as freeze-drying. , It is more preferable to mix 200 to 300 parts by weight of water with 100 parts by weight of seaweed, heat at a temperature of 90 to 95°C for 2 to 3 hours, and then freeze-dry the liquid extract filtered through a sieve to prepare it in powder form.
또한, 상기 녹차 추출물, 율피 추출물, 쌀겨 추출물 및 알로에 추출물은 녹차, 율피, 쌀겨 및 알로에 각각 100 중량부에 정제수 300 내지 500 중량부를 혼합하고 90 내지 100℃의 온도로 1 내지 2시간 동안 열수추출한 후에 여과하는 과정을 통해 제조되는데, 상기의 성분은 왁싱 과정에서 피부자극을 줄여주며, 피부미백 및 진정효과를 부여하는 역할을 한다.In addition, the green tea extract, Yulpi extract, rice bran extract, and aloe extract are obtained by mixing 300 to 500 parts by weight of purified water with 100 parts by weight of green tea, Yulpi, rice bran, and aloe, followed by hot water extraction at a temperature of 90 to 100°C for 1 to 2 hours. It is manufactured through a filtration process, and the above ingredients reduce skin irritation during the waxing process and provide skin whitening and soothing effects.
또한, 상기 피부진정 성분은 10 내지 30 중량부가 함유되며, 올리브 오일 100 중량부, 로즈힙오일 80 내지 120 중량부 및 자일리톨 20 내지 50 중량부로 이루어지는 것이 바람직한데, 상기의 성분으로 이루어지는 피부진정 성분은 우수한 항염, 항소양증, 피부보습 및 피부진정 효과를 나타내면서도 피부 독성이 없는 왁싱용 조성물을 제공하는 역할을 한다.In addition, the skin soothing ingredient contains 10 to 30 parts by weight, preferably consisting of 100 parts by weight of olive oil, 80 to 120 parts by weight of rosehip oil, and 20 to 50 parts by weight of xylitol. The skin soothing ingredient consisting of the above ingredients is an excellent It serves to provide a waxing composition that has anti-inflammatory, anti-pruritic, skin moisturizing and skin soothing effects while being non-toxic to the skin.
상기 올리브 오일은 단백질, 미네랄 및 비타민이 풍부하게 함유되어 있으며, 올레산과 아젤라익산이 함유되어 건성피부나 각질, 모발 등에 영양을 공급해주며, 피부장벽 기능이 강화되어 외부 유해환경에 대한 피부의 방어작용을 증가시켜준다.The olive oil is rich in proteins, minerals, and vitamins, and contains oleic acid and azelaic acid, which provide nutrients to dry skin, dead skin cells, and hair. It strengthens the skin barrier function and acts as a defense mechanism against external harmful environments. increases.
또한, 비타민 A, D 및 E를 함유하고 있어 피부 침투성이 좋고 살결을 유연하게 만들며, 염증 및 가려움증을 억제하고 모발 관리 및 피부 진정 효과에 뛰어나며 겨울에 살이 트는 것을 방지하고, 상처소독 효과가 있어 염증이 있는 피부를 치료하는데 도움을 준다.In addition, it contains vitamins A, D, and E, so it has good skin penetration, makes the skin soft, suppresses inflammation and itching, is excellent for hair care and skin soothing, prevents skin chapped in winter, and has a wound disinfection effect to reduce inflammation. Helps treat irritated skin.
또한, 상기 로즈힙(Rosa Canina)오일은 80 내지 120 중량부가 함유되며, 남미 칠레가 원산지인 장미나무(로즈힙, Rosacanina)의 종자로부터 추출한 오일로, 풍부한 비타민 C와 함께, 비타민 P, 폴리페놀의 일종인 리코펜, 베타-카로틴, 그 밖의 다양한 비타민 군을 함유하고 있는데, 피부 탄력 및 pH 밸런스 유지에 도움을 주며, 피부 진정효과 뿐만 아니라, 주름과 같은 증상 개선 및 조직재생 효과가 우수하다.In addition, the rosehip (Rosa Canina) oil contains 80 to 120 parts by weight and is an oil extracted from the seeds of the rose tree (Rosa Canina), which is native to Chile, South America. It is rich in vitamin C, vitamin P, and a type of polyphenol. It contains lycopene, beta-carotene, and various other vitamins. It helps maintain skin elasticity and pH balance, and has excellent skin soothing effects as well as improving symptoms such as wrinkles and tissue regeneration.
상기 로즈힙 오일의 함량이 80 중량부 미만이면 상기의 효과가 미미하며, 상기 로즈힙 오일의 함량이 120 중량부를 초과하게 되면 상대적으로 올리브 오일의 함량이 지나치게 줄어들어 피부진정 성분의 염증억제 효과가 미미해질 수 있다.If the content of the rosehip oil is less than 80 parts by weight, the above effect is minimal, and if the content of the rosehip oil exceeds 120 parts by weight, the content of olive oil is relatively reduced too much, and the anti-inflammatory effect of the skin soothing ingredient may become insignificant. there is.
또한, 상기 자일리톨은 20 내지 50 중량부가 함유되며, 식물성 원료에 함유된 자일란을 가수분해하여 얻은 자일로스(xylose)를 촉매 존재하에 환원시킨 성분으로, 물에 용해시 흡열반응을 통해 주변을 시원하게 해주는 청량효과가 있고, 피부 보습에도 효과적이기 때문에, 피부온도를 낮춰 진정시킴과 동시에 보습효과를 부여하여 피부를 개선하는 역할을 한다.In addition, the xylitol contains 20 to 50 parts by weight and is a component obtained by reducing xylose obtained by hydrolyzing xylan contained in vegetable raw materials in the presence of a catalyst. When dissolved in water, it cools the surroundings through an endothermic reaction. Because it has a refreshing effect and is effective in moisturizing the skin, it lowers the skin temperature and soothes it, while also improving the skin by providing a moisturizing effect.
이때, 상기 자일리톨의 함량이 20 중량부 미만이면 상기의 효과가 미미하며, 상기 자일리톨의 함량이 50 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 상대적으로 올리브 오일이나 로즈힙 오일의 함량이 지나치게 줄어들기 때문에 바람직하지 못하다.At this time, if the content of xylitol is less than 20 parts by weight, the effect is minimal, and if the content of xylitol exceeds 50 parts by weight, the effect is not significantly improved, but the content of olive oil or rosehip oil is relatively excessive. This is undesirable because it decreases.
또한, 상기 천연 항균제는 1 내지 5 중량부가 함유되며, 금은화 추출물, 어성초 추출물 및 상황버섯 추출물로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는데, 상기의 성분으로 이루어지는 천연 항균제는 세균에 대한 항진균력, 항균력, 살진균력 및 살균력이 우수할 뿐만 아니라, 피부보습 효과를 나타내어 왁싱 후 피부염증이나 가려움증이 발생하는 것을 억제하는 역할을 한다.In addition, the natural antibacterial agent contains 1 to 5 parts by weight and consists of one or more selected from the group consisting of honeysuckle extract, Houttuynia cordata extract, and Sanghwang mushroom extract. The natural antibacterial agent consisting of the above ingredients has antifungal activity, antibacterial activity, Not only does it have excellent fungicidal and sterilizing properties, but it also has a skin moisturizing effect and plays a role in suppressing skin inflammation or itchiness after waxing.
상기 금은화 추출물은 세척한 금은화를 질량농도가 75 내지 85%인 에탄올 수용액에 침지하고 2 내지 4회 환류 추출한 후에, 14 내지 16℃의 온도에서 20 내지 30시간 동안 침적하고 여과하는 과정을 통해 제조된다.The honeysuckle extract is prepared by immersing the washed honeysuckle in an ethanol aqueous solution with a mass concentration of 75 to 85%, extracting the extract under reflux 2 to 4 times, followed by immersion and filtration at a temperature of 14 to 16°C for 20 to 30 hours. .
상기 금은화는(Lonicera japonica Thunb)는 인동과(Caprifoliaceae) 인동속(genus lonicera)에 속하는 인동덩굴의 꽃봉오리 또는 막 피기 시작한 꽃으로, 금은화의 성분으로는 에센셜 오일(정유), 유기산(chlorogenic acid), 플라본(flavones), 이리도이드(iridoids), 사포닌(saponins), 루테올린(luteolin) 등이 있다.The Lonicera japonica Thunb is a flower bud or a flower that has just begun to bloom of the honeysuckle vine belonging to the genus lonicera of the Caprifoliaceae family. Its components include essential oil (essential oil) and organic acid (chlorogenic acid). , flavones, iridoids, saponins, luteolin, etc.
또한, 상기 어성초 추출물은 세척한 어성초를 질량농도가 75 내지 85%인 에탄올 수용액에 침지하고 2 내지 4회 환류 추출한 후에, 14 내지 16℃의 온도에서 20 내지 30시간 동안 침적하고 여과하는 과정을 통해 제조되는데, 상기 어성초는 체내 독소제거, 강장제, 두통제거, 해열의 효능 등이 널리 알려져 있으나, 항바이러스제 및 천연살균제로도 사용될 수 있다.In addition, the Houttuynia cordata extract is obtained by immersing the washed Houttuynia cordata in an ethanol aqueous solution with a mass concentration of 75 to 85%, refluxing and extracting it 2 to 4 times, then immersing and filtering at a temperature of 14 to 16°C for 20 to 30 hours. It is manufactured, and Houttuynia cordata is widely known for its effectiveness in removing toxins from the body, tonic, removing headaches, and relieving fever, but can also be used as an antiviral agent and natural disinfectant.
또한, 상기 상황버섯 추출물은 세척한 상황버섯을 질량농도가 75 내지 85%인 에탄올 수용액에 침지하고 2 내지 4회 환류 추출한 후에, 14 내지 16℃의 온도에서 20 내지 30시간 동안 침적하고 여과하는 과정을 통해 제조된다.In addition, the Sanghwang mushroom extract is prepared by immersing washed Sanghwang mushrooms in an ethanol aqueous solution with a mass concentration of 75 to 85%, refluxing and extracting 2 to 4 times, followed by immersion and filtering at a temperature of 14 to 16°C for 20 to 30 hours. It is manufactured through
상기 상황버섯(桑黃버섯, Phellinus linteus)은 목질진흙버섯이라고도 하며, 베타글루칸 다당체가 다량 함유되어 있는데, 상기 베타글루칸은 대식세포를 활성화시킴으로써 항균효과를 나타내고, 면역력이 저하된 상태에서는 면역력을 향상시키고 과잉일 때는 면역력을 억제하는 면역 조절 기능 및 면역 기능 강화의 효능을 나타낸다.Phellinus linteus is also called woody mud mushroom and contains a large amount of beta-glucan polysaccharides. The beta-glucan exerts an antibacterial effect by activating macrophages and improves immunity in a state of decreased immunity. When in excess, it has an immune-modulating function that suppresses immunity and an effect of strengthening immune function.
상기 천연 항균제의 함량이 1 중량부 미만이면 상기의 효과가 미미하며, 상기 천연 항균제의 함량이 5 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 왁싱용 조성물의 제모효과가 저하될 수 있기 때문에 바람직하지 못하다.If the content of the natural antibacterial agent is less than 1 part by weight, the effect is minimal, and if the content of the natural antibacterial agent exceeds 5 parts by weight, the effect is not significantly improved and the hair removal effect of the waxing composition may be reduced. Therefore, it is not desirable.
또한, 본 발명에 따른 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물에는 상기 왁스 베이스 100 중량부 대비 피부주름 개선제 5 내지 10 중량부가 더 함유될 수도 있는데, 상기 피부주름 개선제는 긴기아남 추출물, 담팔수 추출물 및 참식나무 추출물로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직하다.In addition, the waxing composition exhibiting pain relief and skin soothing effects according to the present invention may further contain 5 to 10 parts by weight of a skin wrinkle improver compared to 100 parts by weight of the wax base, and the skin wrinkle improver includes Gingianam extract, Dampalsu, etc. It is preferable that it consists of one or more selected from the group consisting of extracts and Chinese oak extracts.
상기의 성분으로 이루어지는 피부주름 개선제는 왁싱용 조성물이 도포된 부위에 피부주름을 개선하는 역할을 하는데, 상기 긴기아남 추출물, 담팔수 추출물 및 참식나무 추출물은 긴기아남잎, 담팔수잎 및 참식나무잎 각각을 에탄올에 침지하고 고체성분을 제거하는 과정으로 제조된 추출액을 감압농축하고 동결건조하는 과정을 통해 제조될 수 있다.The skin wrinkle improver consisting of the above ingredients serves to improve skin wrinkles on the area to which the waxing composition is applied. The gingianam extract, gampalsu extract, and eucalyptus tree extract are gingianamm leaf, gampalsu leaf, and eucalyptus tree leaf, respectively. It can be manufactured through a process of immersing in ethanol and removing solid components, concentrating the prepared extract under reduced pressure, and freeze-drying.
상기 피부주름 개선제의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 피부주름 개선제의 함량이 10 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 왁싱용 조성물의 제모효과를 저하시킬 수 있기 때문에 바람직하지 못하다.If the content of the skin wrinkle improver is less than 5 parts by weight, the effect is minimal, and if the content of the skin wrinkle improver exceeds 10 parts by weight, the effect is not significantly improved and the hair removal effect of the waxing composition is reduced. It is undesirable because it can be
또한, 본 발명에 따른 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물에는 상기 왁스 베이스 100 중량부 대비 체모성장 억제용 조성물 1 내지 3 중량부가 더 함유될 수도 있는데, 상기 체모성장 억제용 조성물은 하마엘리스 추출물, 아르니카 추출물, 박하 추출물, 소목 추출물 및 알로에 베라 겔로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직하다.In addition, the waxing composition showing pain relief and skin soothing effects according to the present invention may further contain 1 to 3 parts by weight of a composition for inhibiting hair growth based on 100 parts by weight of the wax base. The composition for inhibiting hair growth is Hamaelis. It is preferable that it consists of one or more selected from the group consisting of extract, arnica extract, peppermint extract, woody extract and aloe vera gel.
상기의 성분으로 이루어지는 체모성장 억제용 조성물은 체모 또는 피부의 단백질 잔기와 공유결합이 가능한 특정 관능기를 도입한 반응성 체모 성장 억제 성분 및/또는 카르보디이미드계 화합물이 함유되어 체모의 성장을 억제할 수 있다.The composition for inhibiting hair growth consisting of the above ingredients contains a reactive hair growth inhibiting ingredient and/or a carbodiimide-based compound that introduces a specific functional group capable of covalently bonding with protein residues of hair or skin, and can inhibit the growth of hair. there is.
이때, 상기 단백질과 공유 결합이 가능한 관능기는 카르보디이미드, 이미도에스터, 아릴아자이드, 디아지린, 하이드록시메틸 포스핀, 펜타플루오로페닐에스터, 피리딜 디설파이드, 설포-하이드록시석신이미드 에스테르, 알콕시 아민, 하이드라자이드, 할로아세틸, 아자이드, 카보네이트, 알데히드, 프로피온알데히드, 부틸알데히드, 니트로페닐카보네이트, 아지리딘, 이소시아네이트, 티오시아네이트, 에폭사이드, 트레실레이트, 숙신이미드, 하이드록시숙신이미딜 에스테르, 이미다졸, 옥시카보닐 아미다졸, 이민, 티올, 말레이미드, 비닐설폰, 에틸렌이민, 티오에테르, 아크릴로나이트릴, 아크릴산 또는 메타크릴산 에스테르, 디설파이드 및 케톤으로 이루어진 그룹에서 선택된 하나 이상으로 이루어질 수 있으나, 이에 한정되지는 않는다,At this time, functional groups capable of covalent bonding with the protein include carbodiimide, imido ester, arylazide, diazirine, hydroxymethyl phosphine, pentafluorophenyl ester, pyridyl disulfide, sulfo-hydroxysuccinimide ester, Alkoxy amine, hydrazide, haloacetyl, azide, carbonate, aldehyde, propionaldehyde, butyraldehyde, nitrophenylcarbonate, aziridine, isocyanate, thiocyanate, epoxide, tresylate, succinimide, hydroxysuccine One selected from the group consisting of imidyl esters, imidazoles, oxycarbonyl amidazoles, imines, thiols, maleimides, vinylsulfones, ethyleneimines, thioethers, acrylonitriles, acrylic or methacrylic acid esters, disulfides and ketones. It can be done as above, but is not limited to this,
또한, 상기 단백질은 티올(thiol), 하이드록실(hydroxyl), 카르복실(carboxyl) 또는 아민(amine)의 반응성 잔기를 포함할 수 있다.Additionally, the protein may contain reactive residues of thiol, hydroxyl, carboxyl, or amine.
상기 하마엘리스 추출물, 아르니카 추출물, 박하 추출물 및 소목 추출물은 하마엘리스, 아르니카, 박하 및 소목 각각을 질량농도가 75 내지 85%인 에탄올 수용액에 침지하고 2 내지 4회 환류 추출한 후에, 14 내지 16℃의 온도에서 20 내지 30시간 동안 침적하고 여과하는 과정을 통해 제조될 수 있다.The Hamaellis extract, arnica extract, peppermint extract, and Cattlewood extract are obtained by immersing each of Hamaellis, arnica, peppermint, and Cattlewood in an aqueous ethanol solution with a mass concentration of 75 to 85%, refluxing and extracting 2 to 4 times, and then extracting it at 14 to 16°C. It can be manufactured through a process of immersion and filtration at temperature for 20 to 30 hours.
상기 체모성장 억제용 조성물의 함량이 1 중량부 미만이면 상기의 효과가 미미하며, 상기 체모성장 억제용 조성물의 함량이 3 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 왁싱용 조성물의 제모효과가 저하될 수 있기 때문에 바람직하지 못하다.If the content of the composition for inhibiting hair growth is less than 1 part by weight, the effect is minimal, and if the content of the composition for inhibiting hair growth exceeds 3 parts by weight, the effect is not significantly improved and the hair removal effect of the composition for waxing is reduced. This is undesirable because the effectiveness may be reduced.
이하에서는, 본 발명에 따른 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물의 제조방법 및 그 제조방법으로 제조된 왁싱용 조성물의 물성을 실시예를 들어 설명하기로 한다.Hereinafter, the method for manufacturing a waxing composition that exhibits pain relief and skin soothing effects according to the present invention and the physical properties of the waxing composition prepared by the method will be described by way of examples.
<제조예 1> 법제유황 분말의 제조<Preparation Example 1> Preparation of legal sulfur powder
광물성 유황을 800℃의 온도로 가열한 후에 110℃의 온도로 냉각하는 과정을 8회 반복한 후에, 150㎛의 입자크기로 분쇄하고, 알칼리 처리(탄산칼슘)과 산처리(식초산)를 반복하여 pH를 7.0으로 조절하는 과정을 통해 법제유황 분말을 제조하였다.The process of heating mineral sulfur to a temperature of 800℃ and then cooling it to a temperature of 110℃ was repeated eight times, then pulverized to a particle size of 150㎛, and repeated alkali treatment (calcium carbonate) and acid treatment (vinegar acid). Thus, legal sulfur powder was prepared through the process of adjusting the pH to 7.0.
<제조예 2> 왁스 베이스의 제조<Preparation Example 2> Preparation of wax base
글리세릴로지네이트 100 중량부, 로진 15 중량부, 에틸렌비닐아세테이트 8 중량부, 파라핀 2 중량부, C30-45 알킬메티콘 8 중량부, 세라알바 12 중량부, 미네랄 오일 18 중량부, 하이드로제네이티드 코코넛 오일 18 중량부, 상기 제조예 1을 통해 제조된 법제유황 분말 8 중량부, 티타늄 디옥사이드 8 중량부 및 안료 8 중량부를 혼합하여 왁스 베이스를 제조하였다.100 parts by weight of glyceryl loginate, 15 parts by weight of rosin, 8 parts by weight of ethylene vinyl acetate, 2 parts by weight of paraffin, 8 parts by weight of C30-45 alkylmethicone, 12 parts by weight of Cera Alba, 18 parts by weight of mineral oil, hydrogenated A wax base was prepared by mixing 18 parts by weight of coconut oil, 8 parts by weight of the sulfur powder prepared through Preparation Example 1, 8 parts by weight of titanium dioxide, and 8 parts by weight of pigment.
<제조예 3> 천연추출물의 제조<Preparation Example 3> Preparation of natural extract
해조류 추출물 분말 100 중량부, 녹차 추출물 100 중량부, 율피 추출물 100 중량부, 쌀겨 추출물 100 중량부 및 알로에 추출물 80 중량부를 혼합하여 천연추출물을 제조하였다.A natural extract was prepared by mixing 100 parts by weight of seaweed extract powder, 100 parts by weight of green tea extract, 100 parts by weight of Yulpi extract, 100 parts by weight of rice bran extract, and 80 parts by weight of aloe extract.
<제조예 4> 피부진정성분의 제조<Preparation Example 4> Preparation of skin soothing ingredients
올리브 오일 100 중량부, 로즈힙오일 100 중량부 및 자일리톨 35 중량부를 혼합하여 피부진정성분을 제조하였다.A skin soothing ingredient was prepared by mixing 100 parts by weight of olive oil, 100 parts by weight of rosehip oil, and 35 parts by weight of xylitol.
<제조예 5> 천연 항균제의 제조<Preparation Example 5> Preparation of natural antibacterial agent
금은화 추출물, 어성초 추출물 및 상황버섯 추출물을 1:1:1의 중량부로 혼합하여 천연 항균제를 제조하였다.A natural antibacterial agent was prepared by mixing honeysuckle extract, Houttuynia cordata extract, and Sanghwang mushroom extract in a ratio of 1:1:1 by weight.
<제조예 6> 피부주름 개선제의 제조<Preparation Example 6> Preparation of skin wrinkle improvement agent
긴기아남 추출물, 담팔수 추출물 및 참식나무 추출물을 1:1:1의 중량부로 혼합하여 피부주름 개선제를 제조하였다.A skin wrinkle improving agent was prepared by mixing gingianam extract, danpal tree extract, and cypress extract in a ratio of 1:1:1 by weight.
<제조예 7> 체모성장 억제용 조성물의 제조<Preparation Example 7> Preparation of composition for inhibiting hair growth
하마엘리스 추출물, 아르니카 추출물, 박하 추출물, 소목 추출물 및 알로에 베라 겔을 1:1:1:1:1의 중량부로 혼합하여 체모성장 억제용 조성물을 제조하였다.A composition for inhibiting hair growth was prepared by mixing hippocampus extract, arnica extract, peppermint extract, woody extract, and aloe vera gel in a weight ratio of 1:1:1:1:1.
<실시예 1><Example 1>
상기 제조예 2를 통해 제조된 왁스 베이스 100 중량부, 상기 제조예 3을 통해 제조된 천연추출물 33 중량부, 상기 제조예 4를 통해 제조된 피부진정 성분 20 중량부 및 상기 제조예 5를 통해 제조된 천연 항균제 3 중량부를 혼합하여 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제조하였다.100 parts by weight of wax base prepared through Preparation Example 2, 33 parts by weight of natural extract prepared through Preparation Example 3, 20 parts by weight of skin soothing ingredient prepared through Preparation Example 4, and Preparation Example 5 A waxing composition showing pain relief and skin soothing effects was prepared by mixing 3 parts by weight of a natural antibacterial agent.
<실시예 2><Example 2>
상기 제조예 2를 통해 제조된 왁스 베이스 100 중량부, 상기 제조예 3을 통해 제조된 천연추출물 25 중량부, 상기 제조예 4를 통해 제조된 피부진정 성분 10 중량부 및 상기 제조예 5를 통해 제조된 천연 항균제 1 중량부를 혼합하여 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제조하였다.100 parts by weight of the wax base prepared through Preparation Example 2, 25 parts by weight of the natural extract prepared through Preparation Example 3, 10 parts by weight of the skin soothing ingredient prepared through Preparation Example 4, and Preparation Example 5 A waxing composition showing pain relief and skin soothing effects was prepared by mixing 1 part by weight of a natural antibacterial agent.
<실시예 3><Example 3>
상기 제조예 2를 통해 제조된 왁스 베이스 100 중량부, 상기 제조예 3을 통해 제조된 천연추출물 40 중량부, 상기 제조예 4를 통해 제조된 피부진정 성분 30 중량부 및 상기 제조예 5를 통해 제조된 천연 항균제 5 중량부를 혼합하여 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제조하였다.100 parts by weight of wax base prepared through Preparation Example 2, 40 parts by weight of natural extract prepared through Preparation Example 3, 30 parts by weight of skin soothing ingredient prepared through Preparation Example 4, and Preparation Example 5 A waxing composition showing pain relief and skin soothing effects was prepared by mixing 5 parts by weight of a natural antibacterial agent.
<실시예 4><Example 4>
상기 실시예 1과 동일하게 진행하되, 상기 제조예 6을 통해 제조된 피부주름 개선제 8 중량부를 더 혼합하여 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제조하였다.Proceeding in the same manner as in Example 1, but further mixing 8 parts by weight of the skin wrinkle improver prepared in Preparation Example 6, a waxing composition exhibiting pain relief and skin soothing effects was prepared.
<실시예 5><Example 5>
상기 실시예 1과 동일하게 진행하되, 상기 제조예 7을 통해 제조된 체모성장 억제용 조성물 2 중량부를 더 혼합하여 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제조하였다.The same procedure as in Example 1 was carried out, but 2 parts by weight of the composition for inhibiting hair growth prepared in Preparation Example 7 was further mixed to prepare a waxing composition exhibiting pain relief and skin soothing effects.
<실시예 6><Example 6>
상기 실시예 1과 동일하게 진행하되, 상기 제조예 6을 통해 제조된 피부주름 개선제 8 중량부 및 상기 제조예 7을 통해 제조된 체모성장 억제용 조성물 2 중량부를 더 혼합하여 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물을 제조하였다.Proceed in the same manner as in Example 1, but further mix 8 parts by weight of the skin wrinkle improver prepared in Preparation Example 6 and 2 parts by weight of the composition for inhibiting body hair growth prepared in Preparation Example 7 to achieve pain relief and skin soothing effects. A waxing composition representing was prepared.
<비교예 1><Comparative Example 1>
글리세릴로지네이트 100 중량부, 설탕 23 중량부, 파라핀 2 중량부, C30-45 알킬메티콘 8 중량부, 미네랄 오일 18 중량부, 하이드로제네이티드 코코넛 오일 18 중량부 및 안료 8 중량부를 혼합하여 왁싱용 조성물을 제조하였다.Waxing by mixing 100 parts by weight of glyceryl loginate, 23 parts by weight of sugar, 2 parts by weight of paraffin, 8 parts by weight of C30-45 alkylmethicone, 18 parts by weight of mineral oil, 18 parts by weight of hydrogenated coconut oil, and 8 parts by weight of pigment. A composition was prepared.
<비교예 2><Comparative Example 2>
상기 실시예 1과 동일하게 진행하되, 상기 제조예 2를 통해 제조된 왁스 베이스 100 중량부, 상기 제조예 3을 통해 제조된 천연추출물 10 중량부, 상기 제조예 4를 통해 제조된 피부진정 성분 5 중량부 및 상기 제조예 5를 통해 제조된 천연 항균제 0.1 중량부를 혼합하여 왁싱용 조성물을 제조하였다.Proceed in the same manner as Example 1, except that 100 parts by weight of the wax base prepared through Preparation Example 2, 10 parts by weight of the natural extract prepared through Preparation Example 3, and 5 skin soothing ingredients prepared through Preparation Example 4 A waxing composition was prepared by mixing 0.1 parts by weight of the natural antibacterial agent prepared through Preparation Example 5.
<비교예 3><Comparative Example 3>
상기 실시예 1과 동일하게 진행하되, 상기 제조예 2를 통해 제조된 왁스 베이스 100 중량부, 상기 제조예 3을 통해 제조된 천연추출물 80 중량부, 상기 제조예 4를 통해 제조된 피부진정 성분 50 중량부 및 상기 제조예 5를 통해 제조된 천연 항균제 10 중량부를 혼합하여 왁싱용 조성물을 제조하였다.Proceed in the same manner as Example 1, except that 100 parts by weight of the wax base prepared through Preparation Example 2, 80 parts by weight of the natural extract prepared through Preparation Example 3, and 50 parts by weight of the skin soothing ingredient prepared through Preparation Example 4 A waxing composition was prepared by mixing 10 parts by weight of the natural antibacterial agent prepared through Preparation Example 5.
상기 실시예 1 내지 6 및 비교예 1 내지 3을 통해 제조된 왁싱용 조성물의 제모효과를 측정하여 아래 표 1에 나타내었으며, 왁싱 후 왁싱용 조성물의 피부 잔존여부를 측정하여 아래 표 2에 나타내었다.The hair removal effects of the waxing compositions prepared in Examples 1 to 6 and Comparative Examples 1 to 3 were measured and shown in Table 1 below, and the residual effect of the waxing composition on the skin after waxing was measured and shown in Table 2 below. .
{단, 제모효과는 20 내지 50대 성인 남녀 30명으로 구성된 피시험자를 대상으로 진행하였으며, 겨드랑이, 다리, 팔 및 음부주변으로 구분하여 나타내었고, 제조된 왁싱용 조성물을 왁싱 부위에 일반적인 도포량으로 도포하고 제모를 진행한 후에 제모효과를 측정하는 방법을 이용하였으며, 제모효과는 5점 척도법으로 조사한 후에 평균값으로 나타내는 방법을 이용하였다. 5점:매우 우수, 4점:우수, 3점:보통, 2점:나쁨, 1점:매우 나쁨{However, the hair removal effect was conducted on test subjects consisting of 30 adult men and women in their 20s to 50s, and was divided into the armpits, legs, arms, and pubic area, and the prepared waxing composition was applied to the waxing area at a typical amount. A method was used to measure the hair removal effect after application and hair removal, and the hair removal effect was examined using a 5-point scale method and expressed as an average value. 5 points: very good, 4 points: excellent, 3 points: average, 2 points: bad, 1 point: very bad
또한, 왁싱용 조성물의 잔존여부는 ◎:매우 잔존, ○:일부 잔존, ×:잔존 없음으로 나타내었다.}In addition, the presence or absence of the waxing composition was indicated as ◎: very much remaining, ○: some remaining, ×: no remaining.}
<표 1><Table 1>
상기 표 1에 나타낸 것처럼, 본 발명의 실시예 1 내지 6을 통해 제조되는 왁싱용 조성물은 우수한 제모효과를 나타내는 것을 알 수 있다. 반면 비교예 1을 통해 제조된 왁싱용 조성물은 평범한 수준의 제모효과를 나타내었으며, 비교예 3을 통해 제조된 왁싱용 조성물은 천연추출물, 피부진정 성분 및 천연 항균제 성분이 지나치게 과량으로 함유되어 제모효과가 저하되는 것을 알 수 있다.As shown in Table 1, it can be seen that the waxing compositions prepared through Examples 1 to 6 of the present invention exhibit excellent hair removal effects. On the other hand, the waxing composition prepared through Comparative Example 1 showed an ordinary level of hair removal effect, and the waxing composition prepared through Comparative Example 3 contained excessive amounts of natural extracts, skin soothing ingredients, and natural antibacterial ingredients, resulting in a low hair removal effect. It can be seen that is decreasing.
<표 2><Table 2>
상기 표 2에 나타낸 것처럼, 본 발명의 실시예 1 내지 6을 통해 제조된 왁싱용 조성물은 제모 후에 피부 잔존이 거의 발생하지 않는데, 비교예 1 및 비교예 3을 통해 제조된 제모용 조성물은 피부 잔존량이 많은 것을 알 수 있다.As shown in Table 2, the waxing compositions prepared in Examples 1 to 6 of the present invention rarely leave skin remaining after hair removal, but the hair removal compositions prepared in Comparative Examples 1 and 3 leave little skin remaining. You can see that the amount is large.
또한, 상기 실시예 1 내지 6 및 비교예 1 내지 3을 통해 제조된 왁싱용 조성물로 진행되는 왁싱과정에서 발생하는 통증의 강도를 측정하여 아래 표 3에 나타내었다.In addition, the intensity of pain occurring during the waxing process using the waxing compositions prepared in Examples 1 to 6 and Comparative Examples 1 to 3 was measured and shown in Table 3 below.
{단, 통증발생 여부는 20 내지 50대 성인 남녀 30명으로 구성된 피시험자를 대상으로 하였으며, 겨드랑이, 다리, 팔 및 음부주변을 대상으로 하여 5점 척도법으로 조사하고 평균값으로 나타내는 방법을 이용하였다.{However, the occurrence of pain was tested on test subjects consisting of 30 adult men and women in their 20s to 50s, and the armpits, legs, arms, and genital area were examined using a 5-point scale method and expressed as the average value.
5점:매우 높음, 4점:높음, 3점:낮음, 2점:매우 낮음, 1점:없음} 5 points: very high, 4 points: high, 3 points: low, 2 points: very low, 1 point: none}
<표 3><Table 3>
상기 표 3에 나타낸 것처럼, 본 발명의 실시예 1 내지 6을 통해 제조된 왁싱용 조성물은 왁싱과정에서 발생하는 통증의 강도가 매우 낮은 것을 알 수 있다, 반면, 비교예 1 내지 2를 통해 제조되는 왁싱용 조성물은 왁싱과정에서 발생하는 통증의 강도가 비교적 높은 것을 알 수 있다.As shown in Table 3, it can be seen that the waxing compositions prepared through Examples 1 to 6 of the present invention have a very low intensity of pain occurring during waxing, whereas the compositions prepared through Comparative Examples 1 to 2 It can be seen that the composition for waxing has a relatively high intensity of pain occurring during the waxing process.
또한, 상기 실시예 1 내지 6 및 비교예 1 내지 3을 통해 제조된 왁싱용 조성물로 왁싱과정을 진행한 후에 피부자극 발생 여부를 측정하여 아래 표 4에 나타내었다.In addition, after the waxing process was performed with the waxing composition prepared in Examples 1 to 6 and Comparative Examples 1 to 3, whether skin irritation occurred was measured and is shown in Table 4 below.
{단, 피부자극 발생여부는 20 내지 50대 성인 남녀 180명으로 구성된 피시험자를 각 실시예 및 비교예 별로 20명씩 편성하여 측정하되, 피부의 건조감, 가려움 및 쓰라림 등의 현상이 발생하는 강도를 5점 척도법으로 조사한 후에 평균값으로 나타내는 방법을 이용하였다.{However, the occurrence of skin irritation was measured by grouping 20 test subjects for each example and comparative example, consisting of 180 adult men and women in their 20s to 50s, and measuring the intensity of phenomena such as skin dryness, itchiness, and soreness. After investigating using a 5-point scale method, a method of expressing the average value was used.
5점:매우 높음, 4점:높음, 3점:낮음, 2점:매우 낮음, 1점:없음5 points: very high, 4 points: high, 3 points: low, 2 points: very low, 1 point: none.
또한, 왁싱 후 7일이 경과한 시점에 피부염증이 발생한 피시험자의 수를 측정하여 나타내었다.}In addition, the number of test subjects who developed skin inflammation 7 days after waxing was measured and shown.}
<표 4><Table 4>
상기 표 4에 나타낸 것처럼, 본 발명의 실시예 1 내지 6을 통해 제조된 왁싱용 조성물을 사용하여 왁싱과정을 진행하면, 피부 자극이 낮고 염증 발생의 빈도가 낮은 것을 알 수 있다.As shown in Table 4, when the waxing process is performed using the waxing composition prepared in Examples 1 to 6 of the present invention, it can be seen that skin irritation is low and the frequency of inflammation is low.
반면, 비교예 1 내지 2와 같이 천연 항균제 성분이 함유되지 않거나 낮은 함량으로 함유된 왁싱용 조성물을 사용하여 왁싱과정을 진행하게 되면 피부자극이 높아질 뿐만 아니라 염증발생의 빈도가 증가하는 것을 알 수 있다.On the other hand, when the waxing process is performed using a waxing composition that does not contain natural antibacterial ingredients or contains low amounts, as in Comparative Examples 1 and 2, not only does skin irritation increase, but the frequency of inflammation increases. .
또한, 상기 실시예 4 내지 6 및 비교예 1 내지 3을 통해 제조된 왁싱용 조성물로 왁싱한 후에 왁싱부위의 주름개선 효과 및 체모성장 억제 효과를 측정하여 아래 표 5에 나타내었다.In addition, after waxing with the waxing composition prepared through Examples 4 to 6 and Comparative Examples 1 to 3, the wrinkle improvement effect and hair growth inhibition effect of the waxing area were measured and shown in Table 5 below.
{단, 주름개선 효과 및 체모성장 억제 효과는 20 내지 50대 성인 남녀 30명으로 구성된 피시험자를 대상으로 다리 부위에 왁싱과정을 2달 간격으로 3회 진행한 후에 5점 척도법으로 조사하고 평균값으로 나타내는 방법을 이용하였다.{However, the wrinkle improvement effect and hair growth inhibition effect were examined using a 5-point scale method after waxing the legs three times at two-month intervals on test subjects consisting of 30 adult men and women in their 20s to 50s, and the average value was calculated. The indicated method was used.
5점:매우 우수, 4점:우수, 3점:보통, 2점:나쁨, 1점:매우 나쁨}5 points: very good, 4 points: excellent, 3 points: average, 2 points: bad, 1 point: very bad}
<표 5> <Table 5>
상기 표 5에 나타낸 것처럼, 본 발명의 실시예 4 내지 6은 주름개선 및 체모성장 억제효과를 나타내는데, 특히, 실시예 6의 경우 주름개선 및 체모성장 억제 효과가 모두 우수한 것을 알 수 있다.As shown in Table 5, Examples 4 to 6 of the present invention demonstrate wrinkle improvement and hair growth inhibition effects. In particular, Example 6 shows excellent wrinkle improvement and hair growth inhibition effects.
따라서, 본 발명에 따른 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물은 우수한 제모효과를 나타내며, 왁싱 과정에서 발생하는 통증을 완화하고 피부를 진정시킬 뿐만 아니라, 세균감염으로 인한 피부염증을 억제한다.Therefore, the composition for waxing that exhibits pain relief and skin soothing effects according to the present invention exhibits an excellent hair removal effect, not only relieves pain occurring during the waxing process and soothes the skin, but also suppresses skin inflammation caused by bacterial infection.
Claims (7)
상기 왁스 베이스는 글리세릴로지네이트 100 중량부, 로진 10 내지 20 중량부, 에틸렌비닐아세테이트 5 내지 10 중량부, 파라핀 1 내지 3 중량부, C30-45 알킬메티콘 5 내지 10 중량부, 세라알바 5 내지 20 중량부, 미네랄 오일 10 내지 25 중량부, 하이드로제네이티드 코코넛 오일 10 내지 25 중량부, 법제유황 분말 5 내지 10 중량부, 티타늄 디옥사이드 5 내지 10 중량부 및 안료 5 내지 10 중량부로 이루어지고,
상기 법제유황 분말은 광물성 유황을 700 내지 900℃의 온도로 가열한 후에 100 내지 120℃의 온도로 냉각하는 과정을 5 내지 10회 반복한 후에, 100 내지 200㎛의 입자크기로 분쇄하고, 알칼리 처리와 산처리를 반복하여 pH를 6.9 내지 7.1의 범위로 조절하는 과정을 통해 제조되며,
상기 천연 추출출은 해조류 추출물 분말 100 중량부, 녹차 추출물 80 내지 120 중량부, 율피 추출물 80 내지 120 중량부, 쌀겨 추출물 80 내지 120 중량부 및 알로에 추출물 70 내지 90 중량부로 이루어지고,
상기 해조류는 미역, 다시마, 우뭇가사리 및 톳으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지며,
상기 피부진성성분은 올리브 오일 100 중량부, 로즈힙오일 80 내지 120 중량부 및 자일리톨 20 내지 50 중량부로 이루어지고,
상기 천연 항균제는 금은화 추출물, 어성초 추출물 및 상황버섯 추출물이 1:1:1의 중량부로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것을 특징으로 하는 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물.
It contains 100 parts by weight of wax base, 25 to 40 parts by weight of natural extract, 10 to 30 parts by weight of skin soothing ingredient, and 1 to 5 parts by weight of natural antibacterial agent,
The wax base includes 100 parts by weight of glyceryl loginate, 10 to 20 parts by weight of rosin, 5 to 10 parts by weight of ethylene vinyl acetate, 1 to 3 parts by weight of paraffin, 5 to 10 parts by weight of C30-45 alkylmethicone, and Cera Alba 5. to 20 parts by weight, 10 to 25 parts by weight of mineral oil, 10 to 25 parts by weight of hydrogenated coconut oil, 5 to 10 parts by weight of sulfur powder, 5 to 10 parts by weight of titanium dioxide, and 5 to 10 parts by weight of pigment,
The legal sulfur powder is prepared by repeating the process of heating mineral sulfur to a temperature of 700 to 900°C and then cooling it to a temperature of 100 to 120°C 5 to 10 times, grinding it to a particle size of 100 to 200㎛, and treating it with alkali. It is manufactured through a process of adjusting the pH to a range of 6.9 to 7.1 by repeating acid treatment.
The natural extract consists of 100 parts by weight of seaweed extract powder, 80 to 120 parts by weight of green tea extract, 80 to 120 parts by weight of Yulpi extract, 80 to 120 parts by weight of rice bran extract, and 70 to 90 parts by weight of aloe extract,
The seaweed consists of one or more selected from the group consisting of seaweed, kelp, agar, and hijiki,
The skin dermatological ingredient consists of 100 parts by weight of olive oil, 80 to 120 parts by weight of rosehip oil, and 20 to 50 parts by weight of xylitol,
The natural antibacterial agent is a composition for waxing that exhibits pain relief and skin soothing effects, characterized in that it consists of one or more selected from the group consisting of honeysuckle extract, Houttuynia cordata extract, and Sanghwang mushroom extract in parts by weight of 1:1:1.
상기 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물에는 상기 왁스 베이스 100 중량부 대비 체모성장 억제용 조성물 1 내지 3 중량부가 더 함유되며,
상기 체모성장 억제용 조성물은 하마엘리스 추출물, 아르니카 추출물, 박하 추출물, 소목 추출물 및 알로에 베라 겔을 1:1:1:1:1의 중량부로 혼합하여 이루어지는 것을 특징으로 하는 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물.
In claim 1,
The waxing composition showing the pain relief and skin soothing effect further contains 1 to 3 parts by weight of a composition for inhibiting hair growth based on 100 parts by weight of the wax base,
The composition for inhibiting body hair growth has a pain relieving and skin soothing effect, characterized in that it is made by mixing hippocampus extract, arnica extract, peppermint extract, cypress extract, and aloe vera gel in parts by weight of 1:1:1:1:1. A composition for waxing.
상기 왁스 베이스는 글리세릴로지네이트 100 중량부, 로진 10 내지 20 중량부, 에틸렌비닐아세테이트 5 내지 10 중량부, 파라핀 1 내지 3 중량부, C30-45 알킬메티콘 5 내지 10 중량부, 세라알바 5 내지 20 중량부, 미네랄 오일 10 내지 25 중량부, 하이드로제네이티드 코코넛 오일 10 내지 25 중량부, 법제유황 분말 5 내지 10 중량부, 티타늄 디옥사이드 5 내지 10 중량부 및 안료 5 내지 10 중량부로 이루어지고,
상기 법제유황 분말은 광물성 유황을 700 내지 900℃의 온도로 가열한 후에 100 내지 120℃의 온도로 냉각하는 과정을 5 내지 10회 반복한 후에, 100 내지 200㎛의 입자크기로 분쇄하고, 알칼리 처리와 산처리를 반복하여 pH를 6.9 내지 7.1의 범위로 조절하는 과정을 통해 제조되며,
상기 천연 추출출은 해조류 추출물 분말 100 중량부, 녹차 추출물 80 내지 120 중량부, 율피 추출물 80 내지 120 중량부, 쌀겨 추출물 80 내지 120 중량부 및 알로에 추출물 70 내지 90 중량부로 이루어지고,
상기 해조류는 미역, 다시마, 우뭇가사리 및 톳으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지며,
상기 피부진성성분은 올리브 오일 100 중량부, 로즈힙오일 80 내지 120 중량부 및 자일리톨 20 내지 50 중량부로 이루어지고,
상기 천연 항균제는 금은화 추출물, 어성초 추출물 및 상황버섯 추출물이 1:1:1의 중량부로 이루어진 그룹에서 선택된 하나 이상으로 이루어지며,
상기 피부주름 개선제는 긴기아남 추출물, 담팔수 추출물 및 참식나무 추출물을 1:1:1의 중량부로 혼합하여 이루어지는 것을 특징으로 하는 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물.
It contains 100 parts by weight of wax base, 25 to 40 parts by weight of natural extract, 10 to 30 parts by weight of skin soothing ingredient, 1 to 5 parts by weight of natural antibacterial agent, and 5 to 10 parts by weight of skin wrinkle improver,
The wax base includes 100 parts by weight of glyceryl loginate, 10 to 20 parts by weight of rosin, 5 to 10 parts by weight of ethylene vinyl acetate, 1 to 3 parts by weight of paraffin, 5 to 10 parts by weight of C30-45 alkylmethicone, and Cera Alba 5. to 20 parts by weight, 10 to 25 parts by weight of mineral oil, 10 to 25 parts by weight of hydrogenated coconut oil, 5 to 10 parts by weight of sulfur powder, 5 to 10 parts by weight of titanium dioxide, and 5 to 10 parts by weight of pigment,
The legal sulfur powder is prepared by repeating the process of heating mineral sulfur to a temperature of 700 to 900°C and then cooling it to a temperature of 100 to 120°C 5 to 10 times, grinding it to a particle size of 100 to 200㎛, and treating it with alkali. It is manufactured through a process of adjusting the pH to a range of 6.9 to 7.1 by repeating acid treatment.
The natural extract consists of 100 parts by weight of seaweed extract powder, 80 to 120 parts by weight of green tea extract, 80 to 120 parts by weight of Yulpi extract, 80 to 120 parts by weight of rice bran extract, and 70 to 90 parts by weight of aloe extract,
The seaweed consists of one or more selected from the group consisting of seaweed, kelp, agar, and hijiki,
The skin dermatological ingredient consists of 100 parts by weight of olive oil, 80 to 120 parts by weight of rosehip oil, and 20 to 50 parts by weight of xylitol,
The natural antibacterial agent consists of one or more selected from the group consisting of honeysuckle extract, Houttuynia cordata extract, and Sanghwang mushroom extract in parts by weight of 1:1:1,
The skin wrinkle improver is a waxing composition that exhibits pain relief and skin soothing effects, characterized in that it is made by mixing gingianam extract, dampalsu extract, and cypress extract in a weight ratio of 1:1:1.
상기 왁스 베이스는 글리세릴로지네이트 100 중량부, 로진 10 내지 20 중량부, 에틸렌비닐아세테이트 5 내지 10 중량부, 파라핀 1 내지 3 중량부, C30-45 알킬메티콘 5 내지 10 중량부, 세라알바 5 내지 20 중량부, 미네랄 오일 10 내지 25 중량부, 하이드로제네이티드 코코넛 오일 10 내지 25 중량부, 법제유황 분말 5 내지 10 중량부, 티타늄 디옥사이드 5 내지 10 중량부 및 안료 5 내지 10 중량부로 이루어지고,
상기 법제유황 분말은 광물성 유황을 700 내지 900℃의 온도로 가열한 후에 100 내지 120℃의 온도로 냉각하는 과정을 5 내지 10회 반복한 후에, 100 내지 200㎛의 입자크기로 분쇄하고, 알칼리 처리와 산처리를 반복하여 pH를 6.9 내지 7.1의 범위로 조절하는 과정을 통해 제조되며,
상기 천연 추출출은 해조류 추출물 분말 100 중량부, 녹차 추출물 80 내지 120 중량부, 율피 추출물 80 내지 120 중량부, 쌀겨 추출물 80 내지 120 중량부 및 알로에 추출물 70 내지 90 중량부로 이루어지고,
상기 해조류는 미역, 다시마, 우뭇가사리 및 톳으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지며,
상기 피부진성성분은 올리브 오일 100 중량부, 로즈힙오일 80 내지 120 중량부 및 자일리톨 20 내지 50 중량부로 이루어지고,
상기 천연 항균제는 금은화 추출물, 어성초 추출물 및 상황버섯 추출물이 1:1:1의 중량부로 이루어진 그룹에서 선택된 하나 이상으로 이루어지며,
상기 피부주름 개선제는 참식나무 추출물로 이루어지는 것을 특징으로 하는 통증완화 및 피부진정 효과를 나타내는 왁싱용 조성물.It contains 100 parts by weight of wax base, 25 to 40 parts by weight of natural extract, 10 to 30 parts by weight of skin soothing ingredient, 1 to 5 parts by weight of natural antibacterial agent, and 5 to 10 parts by weight of skin wrinkle improver,
The wax base includes 100 parts by weight of glyceryl loginate, 10 to 20 parts by weight of rosin, 5 to 10 parts by weight of ethylene vinyl acetate, 1 to 3 parts by weight of paraffin, 5 to 10 parts by weight of C30-45 alkylmethicone, and Cera Alba 5. to 20 parts by weight, 10 to 25 parts by weight of mineral oil, 10 to 25 parts by weight of hydrogenated coconut oil, 5 to 10 parts by weight of sulfur powder, 5 to 10 parts by weight of titanium dioxide, and 5 to 10 parts by weight of pigment,
The legal sulfur powder is prepared by repeating the process of heating mineral sulfur to a temperature of 700 to 900°C and then cooling it to a temperature of 100 to 120°C 5 to 10 times, grinding it to a particle size of 100 to 200㎛, and treating it with alkali. It is manufactured through a process of adjusting the pH to a range of 6.9 to 7.1 by repeating acid treatment.
The natural extract consists of 100 parts by weight of seaweed extract powder, 80 to 120 parts by weight of green tea extract, 80 to 120 parts by weight of Yulpi extract, 80 to 120 parts by weight of rice bran extract, and 70 to 90 parts by weight of aloe extract,
The seaweed consists of one or more selected from the group consisting of seaweed, kelp, agar, and hijiki,
The skin dermatological ingredient consists of 100 parts by weight of olive oil, 80 to 120 parts by weight of rosehip oil, and 20 to 50 parts by weight of xylitol,
The natural antibacterial agent consists of one or more selected from the group consisting of honeysuckle extract, Houttuynia cordata extract, and Sanghwang mushroom extract in parts by weight of 1:1:1,
The skin wrinkle improver is a waxing composition that exhibits pain relief and skin soothing effects, characterized in that it is composed of a Japanese Cuisine extract.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230124077A KR20230142388A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
| KR1020230124081A KR20230142389A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230020928 | 2023-02-16 | ||
| KR20230020928 | 2023-02-16 | ||
| KR20230021668 | 2023-02-17 | ||
| KR1020230021668 | 2023-02-17 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230124081A Division KR20230142389A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
| KR1020230124077A Division KR20230142388A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102581432B1 true KR102581432B1 (en) | 2023-09-25 |
Family
ID=88190392
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230022379A KR102581432B1 (en) | 2023-02-16 | 2023-02-20 | Waxing composition having pain relief and skin soothing effect |
| KR1020230124077A KR20230142388A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
| KR1020230124081A KR20230142389A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230124077A KR20230142388A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
| KR1020230124081A KR20230142389A (en) | 2023-02-16 | 2023-09-18 | Waxing composition having pain relief and skin soothing effect |
Country Status (1)
| Country | Link |
|---|---|
| KR (3) | KR102581432B1 (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070095588A (en) * | 2006-03-22 | 2007-10-01 | 유니크인터네셔널 주식회사 | Nature room composite and the manufacture method for atopiseong skin disease treatment |
| KR20090041886A (en) * | 2007-10-25 | 2009-04-29 | 유한킴벌리 주식회사 | Botanical triple hydro complex and skin care formulation comprising the same |
| KR20150088582A (en) * | 2014-01-24 | 2015-08-03 | 주식회사 엘지생활건강 | Cosmetics compositions for hair growth inhibitor |
| KR101681568B1 (en) * | 2016-03-11 | 2016-12-01 | 박미승 | A wax composition for depilation comprising algae extract and a manufacturing method thereof |
| KR20180065329A (en) * | 2016-12-07 | 2018-06-18 | 농업회사법인 주식회사 제주인디 | Cosmetic composition comprising polygonum indigo flower extract |
| KR101957964B1 (en) | 2017-11-20 | 2019-03-13 | 이미정 | Textile sheet for waxing and method for waxing using the same |
| KR102358671B1 (en) * | 2021-04-13 | 2022-02-08 | 박정임 | Natural hair removal wax composition containing coated sugar and the preparation thereof |
| KR20220101503A (en) * | 2021-01-11 | 2022-07-19 | (주)맘씨생활건강 | A composition for cosmetic |
| KR102438866B1 (en) | 2021-01-12 | 2022-09-01 | 주식회사 르하임아나덴 | Method for face waxing |
-
2023
- 2023-02-20 KR KR1020230022379A patent/KR102581432B1/en active IP Right Grant
- 2023-09-18 KR KR1020230124077A patent/KR20230142388A/en active Application Filing
- 2023-09-18 KR KR1020230124081A patent/KR20230142389A/en active Application Filing
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070095588A (en) * | 2006-03-22 | 2007-10-01 | 유니크인터네셔널 주식회사 | Nature room composite and the manufacture method for atopiseong skin disease treatment |
| KR20090041886A (en) * | 2007-10-25 | 2009-04-29 | 유한킴벌리 주식회사 | Botanical triple hydro complex and skin care formulation comprising the same |
| KR20150088582A (en) * | 2014-01-24 | 2015-08-03 | 주식회사 엘지생활건강 | Cosmetics compositions for hair growth inhibitor |
| KR101681568B1 (en) * | 2016-03-11 | 2016-12-01 | 박미승 | A wax composition for depilation comprising algae extract and a manufacturing method thereof |
| KR20180065329A (en) * | 2016-12-07 | 2018-06-18 | 농업회사법인 주식회사 제주인디 | Cosmetic composition comprising polygonum indigo flower extract |
| KR101957964B1 (en) | 2017-11-20 | 2019-03-13 | 이미정 | Textile sheet for waxing and method for waxing using the same |
| KR20220101503A (en) * | 2021-01-11 | 2022-07-19 | (주)맘씨생활건강 | A composition for cosmetic |
| KR102438866B1 (en) | 2021-01-12 | 2022-09-01 | 주식회사 르하임아나덴 | Method for face waxing |
| KR102358671B1 (en) * | 2021-04-13 | 2022-02-08 | 박정임 | Natural hair removal wax composition containing coated sugar and the preparation thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230142389A (en) | 2023-10-11 |
| KR20230142388A (en) | 2023-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101997177B1 (en) | Shampoo composition for improving state of scalp and hair | |
| KR20080108718A (en) | Cosmetic composition for skin massage comprising natural softened plants and manufacturing method thereof | |
| KR101189989B1 (en) | Cosmetic composition containing as available ingredient the extracts of Equisetum arvense L. | |
| CN110420152A (en) | A kind of salubrious mild double-deck make up remover and preparation method thereof | |
| KR101412713B1 (en) | Natural Soap by using of Ripen and Decocted Oriental Medicine with the function of making age spots and wrinkles better and Manufacturing Method thereof | |
| KR100891986B1 (en) | Cosmetic composition containing herb medicine extracts and powders | |
| KR101893085B1 (en) | Functional soap and manufacturing method of the same | |
| KR102300581B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
| KR20140145278A (en) | Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect | |
| KR20190074663A (en) | Natural soap composition | |
| KR102561149B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR102581432B1 (en) | Waxing composition having pain relief and skin soothing effect | |
| KR100979143B1 (en) | Cosmetic composition containing herb extract for skin moisturizing effect and for enhancing skin elasticity | |
| CN110613663A (en) | Skin repairing composition, skin care product and preparation method thereof | |
| KR20170099096A (en) | Cosmetic Composition for improving Skin-Wrinkle | |
| KR102585726B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR20160118417A (en) | Manufacturing Method and Composion for Viper Venom Liquid Mixture | |
| JPS61158912A (en) | Composition for amelioration of skin | |
| KR20230152511A (en) | Cosmetic composition in relieving skin for skin regenerating, Manufacturing method thereof, and Cosmetics containing the same | |
| KR20230081341A (en) | Shampoo for fine hair improvement with herbal extracts | |
| KR20150105721A (en) | Skin-antiaging cosmetical composition containing mixed extract of lycium chinense mill as an active ingredient | |
| KR102062822B1 (en) | Functional soap containing a composition to prevent hair loss and manufacturing method of the same | |
| KR20150120110A (en) | Make-up soap composition containing medicinal herbs extract, amino acid complex and manufacturing method thereof | |
| RU2694830C1 (en) | Sugar body scrubs | |
| RU2685242C1 (en) | Sugar body scrubs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right | ||
| A107 | Divisional application of patent | ||
| GRNT | Written decision to grant |